Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines
European Pharmaceutical Review
JUNE 29, 2022
How does that impact the safety of the biologics? Safety is key to the development of any medicine, but the safety considerations linked to bioproduction are more complex because biologics are more sophisticated medicines than small molecules. London: European Medicines Agency; 2016 [cited May 2022]. References.
Let's personalize your content